Author's posts
Language Barrier Means Millions Of Elderly Can’t Access Alzheimer’s Trials
In the U.S., Alzheimer’s clinical trials are largely limited to fluent English speakers, which leaves millions of patients without the opportunity to participate and scientists without diverse data.
